The tariff classification of ANTEGREN® (natalizumab) mixed with excipients and imported in bulk form, and ANTEGREN® (natalizumab) mixed with excipients and imported put up in single-dose vials, from Germany and other countries
Reasoning
The tariff classification of ANTEGREN® (natalizumab) mixed with excipients and imported in bulk form, and ANTEGREN® (natalizumab) mixed with excipients and imported put up in single-dose vials, from Germany and other countries
Cite this ruling
CBP Ruling K86861 (3003900000): The tariff classification of ANTEGREN® (natalizumab) mixed with excipients and imported in bulk form, and ANTEGREN® (natalizumab) mixed with excipients and imported put up in single-dose vials, from Germany and other countries
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300390
The tariff classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
The tariff classification of granules composed of (by weight) 50% calcium carbonate, 38% sugar and 12% starch, for use in the manufacture of antacid tablets, imported in bulk form, from Canada
The tariff classification of Acetaminophen DC-90, imported in bulk form, from China
The tariff classification of granules composed of (by weight) 50% calcium carbonate, 38% sugar and 12% starch, for use in the manufacture of antacid tablets, imported in bulk form, from Canada
onstituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: other. We have reconsidered that ruling and determined that the classification was incorrect. The correct classification for the articles is in subheading 3824.90.2800, HTSUS, pursuant to the analysis set forth below.